Literature DB >> 1835823

Behavioral and histopathologic effects following intrathecal administration of butorphanol, sufentanil, and nalbuphine in sheep.

N Rawal1, L Nuutinen, P P Raj, S L Lovering, A H Gobuty, J Hargardine, L Lehmkuhl, R Herva, E Abouleish.   

Abstract

A large number of opioids and nonopioids have been administered epidurally and intrathecally in the hope of providing segmental analgesia without serious adverse effects. However, neurotoxicity data are generally unavailable for many of these drugs. The present study evaluated the behavioral, motor, electroencephalographic, and histopathologic changes following intrathecal injection of large and small doses of butorphanol, sufentanil, and nalbuphine in sheep. Thirty-two sheep (20-32 kg) were anesthetized and catheters placed intrathecally after hemilaminectomy. The large doses of butorphanol, sufentanil and nalbuphine were 0.375 mg/kg (4.4-5.2 ml), 7.5 micrograms/kg (3.6-4.8 ml) and 0.75 mg/kg (1.5-2.4 ml), and the small doses were 0.075 mg/kg (0.9-1.1 ml), 1.5 micrograms/kg (0.7-0.9 ml) and 0.15 mg/kg (0.38-0.5 ml), respectively. The opioids were administered intrathecally every 6 h for 3 days and the above-mentioned parameters studied. Five sheep received intrathecal saline (1.1 or 5.2 ml) and served as controls. Histopathologic changes were evaluated by a neuropathologist blinded to the study protocol. Irrespective of dose, intrathecal injection of butorphanol was associated with severe behavioral responses such as agitation, rigidity, vocalization, and restlessness, as well as prolonged or irreversible hindlimb paralysis. Electroencephalography showed increased cortical activity or seizure activity. One sheep died because of severe respiratory depression that did not respond to naloxone. Spinal cord histologic changes consisted of suppurative meningitis and myelitis as well as neuronal changes such as spongiosis and chromatolysis. Large doses of intrathecal sufentanil were associated with similar though somewhat less severe responses. The behavioral and motor changes following the small dose of intrathecal sufentanil were of mild to moderate nature. Following intrathecal nalbuphine, the above-mentioned changes were similar to those seen in control animals. We conclude that butorphanol in doses of 0.075 and 0.375 mg/kg intrathecally and sufentanil 7.5 micrograms/kg intrathecally are neurotoxic in sheep.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835823     DOI: 10.1097/00000542-199112000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

1.  Sufentanil Alleviates Intrathecal Lidocaine Induced Prolonged Sensory and Motor Impairments but not the Spinal Histological Injury in Rats.

Authors:  Zhong Zhang; Yuan Chen; E Wang; Lei Wu; Ruike Wang; Zongbin Song; Yingqi Weng; Zhihua Sun; Qulian Guo; Yunping Li
Journal:  Neurochem Res       Date:  2018-04-27       Impact factor: 3.996

Review 2.  Use of nerve block techniques for postoperative analgesia.

Authors:  Per H Rosenberg
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

Review 3.  Side effects of intrathecal and epidural opioids.

Authors:  M A Chaney
Journal:  Can J Anaesth       Date:  1995-10       Impact factor: 5.063

4.  [The clinical use of spinal opioids, part 1].

Authors:  N Rawal
Journal:  Schmerz       Date:  1996-08-26       Impact factor: 1.107

5.  A Comparative Study of Analgesic Effect of Intrathecal Nalbuphine and Fentanyl as Adjuvant in Lower Limb Orthopaedic Surgery.

Authors:  Shagufta Naaz; Usha Shukla; Swati Srivastava; Erum Ozair; Adil Asghar
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 6.  Side Effects and Efficacy of Neuraxial Opioids in Pregnant Patients at Delivery: A Comprehensive Review.

Authors:  Sarah Armstrong; Roshan Fernando
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

Review 7.  Intrathecal analgesic drug therapy.

Authors:  Alan Farrow-Gillespie; Kimberly M Kaplan
Journal:  Curr Pain Headache Rep       Date:  2006-02

Review 8.  Spinal drug delivery.

Authors:  T S Grabow; D Derdzinski; P S Staats
Journal:  Curr Pain Headache Rep       Date:  2001-12

9.  Intrathecal nalbuphine as an adjuvant to subarachnoid block: What is the most effective dose?

Authors:  Arghya Mukherjee; Anirban Pal; Jitendra Agrawal; Amrita Mehrotra; Nidhi Dawar
Journal:  Anesth Essays Res       Date:  2011 Jul-Dec

10.  Nalbuphine versus Midazolam as an Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section.

Authors:  Olfat Abdelmoniem Ibrahem Amin; Mohamed Abdel-Moniem Ibrahem; Dina Abdelhameed Elsadek Salem
Journal:  J Pain Res       Date:  2020-06-11       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.